phosphoramidic acid has been researched along with Hallervorden-Spatz Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frank, M; Jackowski, S; Pate, C; Rock, CO; Zano, SP | 1 |
1 other study(ies) available for phosphoramidic acid and Hallervorden-Spatz Disease
Article | Year |
---|---|
Correction of a genetic deficiency in pantothenate kinase 1 using phosphopantothenate replacement therapy.
Topics: Administration, Oral; Amides; Animals; Coenzyme A; Disease Models, Animal; Embryo, Mammalian; Female; Fibroblasts; Gene Expression; Humans; Liver; Male; Mice; Mice, Knockout; Pantothenate Kinase-Associated Neurodegeneration; Pantothenic Acid; Phosphoric Acids; Phosphotransferases (Alcohol Group Acceptor); Primary Cell Culture | 2015 |